FDA Warns Of Birth Defects Risk with Diflucan

more+
less-

The FDA is warning the public that treatment with chronic, high doses of Diflucan (fluconazole) during the first trimester of pregnancy may be associated with a rare and distinct set of birth defects in infants. Diflucan is prescribed for fungal infections and infections arising out of chemotherapy or radiation therapy.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  Birth Defects, Drug Safety, FDA, Pharmaceutical, Pregnancy, Prescription Drugs, Side Effects

Published In: Health Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© TorHoerman Law, LLC | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »